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Who Is David and Who Is Goliath?
There Is an Urgent Need to Improve the Reference Standards for Estimation
of Myocardial Infarct Size*
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wCurrently, cardiac troponins (cTn) are well estab-
lished for diagnosis, risk stratification, and guidance
of the therapeutic strategy in patients with sus-
pected acute coronary syndromes (1). Cardiac tro-
ponin T and I are ideally suited for the detection of
myocardial damage because they are expressed in
high intracellular concentrations as cardio-specific
isoforms. The vast majority of the troponin com-
plex is immobilized on the thin filament of striated
muscle, and only a minor fraction exists as a soluble
See page 523
pool, which eventually represents a precursor pool
of sarcomere assembly (2). Following irreversible
cell damage, cTn are released by disintegration and
degradation of the sarcomere, and can be measured
in the blood for days to weeks, despite a short
half-life in the circulation of only 90 min. As a
consequence, the time-dependent concentration
changes of troponin T in the blood of patients with
acute myocardial infarction (AMI) reflect distinct
washout and release mechanisms that may serve as
surrogates of microvascular reperfusion and infarct
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learly correlate with reperfusion therapy and time
rom onset of symptoms to recanalization of the
nfarct-related artery. Accordingly, a pronounced
ashout on day 1 corresponds to successful reper-
usion therapy, whereas the absence of an early peak
s only observed in nonreperfused myocardial in-
arction (2). The blood levels of troponin T on day
to 4, however, result from degradation of the
ontractile apparatus and are released at times of
esuming blood flow to the infarct zone. This late
elease is considered a hallmark of irreversible myo-
ardial injury and has been shown to reflect infarct
ize, both in animals (3) and patients (4,5).
On the other hand, imaging modalities are also
ell established for infarct imaging and quantifica-
ion of infarct size including single-photon emis-
ion computed tomography (SPECT), positron
mission tomography (PET), and late gadolinium-
nhanced cardiac magnetic resonance (LGE-
MR) (6).
In this issue of iJACC, Miller et al. (7) present
heir findings on the relationship between serially
etermined cTnT concentrations and infarct size
sing gated SPECT myocardial perfusion imaging
MPI) as the reference method. SPECT-MPI was
erformed a median of 10 days post-AMI. The
tudy cohort comprised 121 patients with first AMI
n whom cTnT was obtained serially on presenta-
ion, after 12 h, and every 24 h for 4 days or longer.
he authors found that the SPECT-defined infarct
ize closely correlated with cTnT concentrations at 12
o 24 h, on day 2, day 3, and peak cTnT concentra-
ions but not with admission troponin values. In
ddition, there was a significant inverse correlation
etween cTnT concentrations on days 1, 2, and 3, and
ith peak cTnT concentration with left ventricular
jection fractions. Receiver-operating characteristic
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535curve analysis determined a peak cTnT cutoff value of
1.5 ng/ml for detection of SPECT-defined infarction
that corresponds to 150  the 99th percentile, the
pper limit of normal. Finally, infarct size and peak
TnT were associated with major cardiac events at
ollow-up, supporting the prognostic relevance of
irect and indirect estimates of infarct size. The most
nteresting finding of this study, however, is that
lmost one-half (49%) of the patients had no detect-
ble infarct using SPECT-MPI. Thus, this study
ighlights the increasingly important issue about the
ppropriateness of current reference standards regard-
ng spatial resolution for accurate estimation of infarct
ize, in particular when patients with smaller infarcts
re analyzed.
SPECT is the most commonly performed car-
iac imaging technique in nuclear cardiology. Cur-
ently, there are more than 8 million cardiac
PECT procedures but 50,000 cardiac PET pro-
cedures performed annually in the United States
(8). As compared with PET or SPECT, CMR has
the advantage of non-ionizing imaging of myocar-
dial morphology, systolic and diastolic function,
and myocardial perfusion and viability with high
spatial and temporal resolution. The extent of
abnormal gadolinium enhancement linearly corre-
lates with the histological area of myocardial infarc-
tion in both acute and chronic myocardial infarction
in animal models (9). High spatial resolution en-
ables detection of small, subendocardial infarction,
which is difficult to detect with radionuclide imag-
ing. In an animal study using histopathology spec-
imens as the reference, LGE-CMR identified 92%
of the segments with a subendocardial infarction,
whereas SPECT detected only 28% (10), possibly
due to the lower spatial resolution of SPECT of
only 10 mm. Thus, infarcts restricted to the suben-
docardial layers of the myocardium may escape
detection by SPECT. Although LGE-CMR may
provide higher spatial resolution, it still may not
qualify as a reference method for estimation of
infarct size in non–ST-segment elevation myocar-
dial infarction (NSTEMI) populations. With the
commonly applied method of LGE-CMR imaging,
the minimum detectable LGE necrosis is a group of
10 hyperenhanced pixels corresponding to a voxel of
1.9  1.4  7 mm (11,12). Accordingly, CMR has
een reported to visualize infarcts amounting to a
ass of 1 to 2 g in clinical studies (12). Thus, inue to inadequate spatial resolution or partial vol-
me effects at the interface between blood and the
ndocardial border.
A previous study from our group (4) reported an
nferior performance of single-point and serial tro-
onin measurements for detection of small infarcts
13.6 g), NSTEMI, and nonanterior infarct lo-
ation. In the present study, Miller et al. (7) provide
dditional evidence by yet another imaging method
hat there is currently no appropriate reference
ethod when a small infarct is detected by sensitive
roponin assays. In their study, the receiver-
perator characteristic curve concentrations of
TnT to detect SPECT-defined infarcts were as
igh as 1.5 ng/ml, which corresponds to 150 
he 99th percentile, the upper limit of normal. Not
urprisingly 49% of all infarcts, particularly
STEMI, were not detectable by SPECT. More
ecently, Lim et al. (12) studied 32 patients under-
oing multivessel percutaneous coronary interven-
ion to evaluate the relationship between troponin
ise and peri-interventional infarctions. The authors
ailed to detect the majority of cTn-defined post-
nterventional myocardial infarcts (type IVa) using
GE-CMR imaging. From this finding, the au-
hors draw the conclusion that low cTn thresholds
ere too sensitive for diagnosis of peri-interventional
yocardial infarction, instead of questioning the low
patial resolution of current CMR imaging. Obvi-
usly, estimation of the size of smaller infarcts is an
ssue, not of oversensitivity of the current troponin
hresholds, but of undersensitivity of the current im-
ging modalities as reference standards.
Thus, when smaller infarct sizes have to be assessed,
hich are detectable by the now widely used troponin
ssays, better imaging modalities with higher spatial
esolution and higher signal-to-noise ratios must be
pplied. In the near future, this ambitious goal may be
chieved by development and broader use of high-
eld magnetic resonance imaging technology (3-T or
igher), improved cardiac radiofrequency coils, novel
ulse sequences allowing high resolution T1 mapping
f the heart, and other novel technologies that aim to
urther increase spatial resolution.
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